From 14:00 Registration and Reception

15:00 Welcome address

• Representative of the University boards, LMU
• Prof. Dr. med. Markus Lerch, Chief Executive Officer, LMU Klinikum
• Prof. Dr. med. Julia Mayerle, Vice Dean of the Medical Faculty of LMU
• Prof. Dr. med. Dr. rer. nat. Michael von Bergwelt-Baildon, Speaker DKTK-site

Moderation: Kathrin Gabriel, Student Representative i-Target 2.0 and Dr. med. Thu Nguyen, Clinician Scientist Fellow Representative, IOLIN

15:30 Laurence Zitvogel, M.D., PhD, Professor, Gustave Roussy Cancer Center, Paris: “Harnessing the microbiome in immunotherapies”

15:55 Christian Klein, PhD, CSO, Biotech Start-up, Zürich, Switzerland: “Next generation protein-therapeutics in cancer immunotherapy”

16:20 Simon Grassmann, M.D., Instructor, Memorial Sloan Kettering Cancer Center, New York, USA: “New insights into NK cell biology – implications for therapy”

16:45 Sebastian Kobold, M.D., Professor and Director, Institute for Clinical Pharmacology, LMU Klinikum: “Engineering T cells for next generation cancer therapeutics”

Closing Remarks: Prof. Dr. med. Sebastian Kobold

From 17:15 Reception in the Foyer and Court of St. Vinzenz House